Skeletal Histomorphometry in Patients on Teriparatide or Zoledronic Acid Therapy.

Trial Profile

Skeletal Histomorphometry in Patients on Teriparatide or Zoledronic Acid Therapy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Sep 2014

At a glance

  • Drugs Teriparatide (Primary) ; Zoledronic acid
  • Indications Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Acronyms SHOTZ
  • Sponsors Eli Lilly
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 05 Oct 2013 Twenty-four month results presented at the 35th Annual Meeting of the American Society for Bone and Mineral Research.
    • 15 Oct 2012 Results from this trial presented at the 34th Annual Meeting of the American Society for Bone and Mineral Research (ASBMR), according to an Eli Lilly media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top